Citizens And 2 Other Stocks Under $3 Insiders Are Buying
Citizens And 2 Other Stocks Under $3 Insiders Are Buying
Citizens 和其他两只低于3美元的股票内部人士正在买入
The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周一收盘下跌约10点。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
Citizens
市民
- The Trade: Citizens, Inc. (NYSE:CIA) Director Terry Sam Maness acquired a total of 1,000 shares an average price of $2.14. To acquire these shares, it cost around $2,137.
- What's Happening: On March 18, Citizens, named Jon Stenberg as President of Citizens.
- What Citizens Does: Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States.
- 贸易：公民公司（纽约证券交易所代码：CIA）董事特里·萨姆·马内斯 共收购了 1,000 股股份 平均价格为2.14美元。收购这些股票的成本约为2,137美元。
- 发生了什么：3月18日，公民任命乔恩·斯坦伯格为公民总统。
- 公民做什么：Citizens Inc是一家保险控股公司，为美国个人的人寿保险需求提供服务。
Tecogen
Tecogen
- The Trade: Tecogen Inc. (OTC:TGEN) Director John Hatsopoulos acquired a total of 1,000 shares at at an average price of $0.70. To acquire these shares, it cost around $700.
- What's Happening: On March 13, Tecogen reported revenues of $5.9 million and a net loss of $1.8 million for the quarter ended Dec. 31, 2023.
- What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.
- 交易：Tecogen Inc.（场外交易代码：TGEN）董事约翰·哈索普洛斯 共收购了1,000股股票 平均价格为0.70美元。收购这些股票的成本约为700美元。
- 发生了什么：3月13日，Tecogen公布截至2023年12月31日的季度收入为590万美元，净亏损180万美元。
- Tecogen做什么：Tecogen公司设计、制造、销售和维护高效、超清洁的热电联产产品。它分为三个业务领域，即产品、服务和能源生产。
Silo Pharma
思洛制药
- The Trade: Silo Pharma, Inc. (NASDAQ:SILO) CEO and President Eric Weisblum acquired a total of 1,000 shares at an average price of $1.99. The insider spent around $1,988 to buy those shares.
- What's Happening: Silo Pharma approved extension of previously announced stock repurchase program authorizing purchase of up to $1 million common stock until April 30.
- What Silo Pharma Does: SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases.
- 交易：Silo Pharma, Inc.（纳斯达克股票代码：SILO）首席执行官兼总裁埃里克·魏斯布鲁姆 共收购了 1,000 股股份 平均价格为1.99美元。知情人士花费了约1,988美元购买了这些股票。
- 发生了什么：Silo Pharma批准将先前宣布的股票回购计划延长至4月30日，该计划授权购买高达100万美元的普通股。
- Silo Pharma做什么：SILO Pharma Inc是一家处于发展阶段的生物制药公司，正在开发新疗法，以解决服务不足的疾病，包括压力诱发的精神疾病、慢性疼痛和中枢神经系统（CNS）疾病。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道